Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
about
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
description
clinical trial
@en
klinisch onderzoek
@nl
name
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
@en
type
label
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
@en
prefLabel
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
@en
P1050
P1476
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients (COUP-1)
@en
P3098
NCT03474744
P4844
P580
2019-06-01T00:00:00Z
P582
2028-06-01T00:00:00Z